SAT

Pulmonary Hypertension Machine Learning-Based Notification Software

Product code
SAT
Device name
Pulmonary Hypertension Machine Learning-Based Notification Software
Device class
Class 2
21 CFR
21 CFR 870.2380
Medical specialty
Cardiovascular
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

Pulmonary hypertension machine learning-based notification software employs machine learning techniques to suggest the likelihood of pulmonary hypertension for further referral or diagnostic follow-up.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-08-21.

NumberDecision dateApplicantDevice nameSummary
K2536992026-08-21Tempus AI, Inc.Tempus ECG-PHFDA
K2523602026-03-28Anumana, Inc.ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithmPDF
K2336662024-04-05Analytics For Life, Inc.CorVista System with PH Add-OnPDF

2 summaries are archived here for direct download.

Official FDA classification page: SAT
Classification and pathway per current FDA publications. Data from openFDA (CC0).